SynthesisSurgical endoscopy2025
Comparative 30-day mortality and complications in robotic vs. open pancreaticoduodenectomy with portal-mesenteric vein resection: a systematic review and meta-analysis.
Synthesis in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Robotic pancreaticoduodenectomy with venous resection and reconstruction: a systematic review of perioperative, vascular, oncological and survival outcomes.Journal of robotic surgery · 2026Pooled it
- Robotic versus open pancreaticoduodenectomy in elderly patients: a meta-analysis.Frontiers in oncology · 2026Pooled it
- Robotic portomesenteric vein reconstruction using self-fashioned bovine pericardial grafts during Da Vinci-assisted pancreatectomy: a case series with video demonstration.Surgical endoscopy · 2026Article
- ASO Author Reflections: Unexpected Intraoperative Positive Ductal Margin in Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Hepatopancreatoduodenectomy Always Necessary?Annals of surgical oncology · 2026Article
- Minimally Invasive Pancreatoduodenectomy for Pancreatic Cancer: Current Perspectives and Future Directions.Cancers · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPortal-mesenteric vein resection (PMVR) is often necessary for pancreatic ductal adenocarcinoma (PDAC) with vascular invasion. While open pancreaticoduodenectomy (OPD) is the standard approach, robotic pancreaticoduodenectomy (RPD) offers a minimally invasive alternative with potential benefits but faces challenges related to technical complexity and safety. This meta-analysis compares perioperative outcomes of RPD with PMVR versus OPD with PMVR in PDAC.
methodsA search of PubMed, Google Scholar, EMBASE, and the Cochrane Central Register of Controlled Trials identified observational studies published from January 2010 to September 2024. Studies included compared RPD and OPD with PMVR in PDAC, reporting 30-day mortality, major complications (Clavien-Dindo classification), and complications such as postoperative pancreatic fistulas (POPF), delayed gastric emptying (DGE), and post-pancreatectomy hemorrhage (PPH). Pooled estimates were calculated using a random-effects model.
resultsFour studies involving 288 patients met inclusion criteria (RPD + PMVR: n = 69; OPD + PMVR: n = 219). Thirty-day mortality (6.3% vs 5.6%, OR: 1.29, 95% CI 0.41-4.03, p = 0.66, I
conclusionsRPD + PMVR is comparable to OPD + PMVR in terms of safety and efficacy, with the added benefit of reduced hospital LOS.
Indexed as
Identifiers
40775468What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.